By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – TriLink BioTechnologies today said that it has received a Phase II Small Business Innovation Research grant of around $725,000 to continue its studies of DNA ligase.

The San Diego-based firm said that it will use the funds to continue its research on chemically modified components as a means of enhancing ligation fidelity in a variety of applications including SNP detection, proximity ligation, and sequencing by ligation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.